Christopher Coughlin Biography and Net Worth

Director of Centene


Christopher J. Coughlin serves as Independent Director of the Company. Mr. Coughlin served as Advisor to the Chairman and CEO of Tyco International Ltd., a global provider of diversified products, services and industries, from 2010 to 2012, and as Executive Vice President and Chief Financial Officer of Tyco from 2005 to 2010, during a period of significant international growth and restructuring. Mr. Coughlin previously served at the Interpublic Group of Companies, Inc. as Executive Vice President, Chief Operating Officer from 2003 to 2004. From 1998 to 2003, he served as Executive Vice President and Chief Financial Officer of Pharmacia Corporation. From 1997 to1998, he was President, International at Nabisco Group Holdings and from 1996 to 1997 was Executive Vice President and Chief Financial Officer of Nabisco. From 1981 to 1996, Mr. Coughlin held various positions with Sterling Winthrop Incorporated, including Chief Financial Officer. Mr. Coughlin received a BS in accounting from Boston College. Mr. Coughlin is an audit committee financial expert.

What is Christopher J. Coughlin's net worth?

The estimated net worth of Christopher J. Coughlin is at least $1.84 million as of May 14th, 2024. Mr. Coughlin owns 25,504 shares of Centene stock worth more than $1,838,328 as of October 6th. This net worth evaluation does not reflect any other investments that Mr. Coughlin may own. Learn More about Christopher J. Coughlin's net worth.

How do I contact Christopher J. Coughlin?

The corporate mailing address for Mr. Coughlin and other Centene executives is 7700 FORSYTH BOULEVARD, ST LOUIS MO, 63105. Centene can also be reached via phone at (314) 725-4477 and via email at [email protected]. Learn More on Christopher J. Coughlin's contact information.

Has Christopher J. Coughlin been buying or selling shares of Centene?

Christopher J. Coughlin has not been actively trading shares of Centene during the past quarter. Most recently, Christopher J. Coughlin sold 878 shares of the business's stock in a transaction on Tuesday, May 14th. The shares were sold at an average price of $76.75, for a transaction totalling $67,386.50. Following the completion of the sale, the director now directly owns 25,504 shares of the company's stock, valued at $1,957,432. Learn More on Christopher J. Coughlin's trading history.

Who are Centene's active insiders?

Centene's insider roster includes Andrew Asher (Exec. VP & CFO ), Andrew Asher (CFO), Orlando Ayala (Director), Shannon Bagley (EVP), Mark Brooks (EVP), Kenneth Burdick (EVP), Brandy Burkhalter (COO), Katie Casso (SVP), Christopher Coughlin (Director), Robert Ditmore (Director), Kenneth Fasola (President), Richard Gephardt (Director), Jesse Hunter (NASDAQ), Christopher Koster (SVP), Brent Layton (EVP), Sarah London (CEO), Michael Neidorff (CEO), John Roberts (Director), Lori Robinson (Director), Theodore Samuels, II (Director), Jeffrey Schwaneke (CFO), David Thomas (EVP), Tommy Thompson (Director), and Colin Toney (EVP). Learn More on Centene's active insiders.

Are insiders buying or selling shares of Centene?

In the last twelve months, insiders at the sold shares 4 times. They sold a total of 30,878 shares worth more than $2,363,286.50. The most recent insider tranaction occured on May, 14th when Director Christopher J Coughlin sold 878 shares worth more than $67,386.50. Insiders at Centene own 0.3% of the company. Learn More about insider trades at Centene.

Information on this page was last updated on 5/14/2024.

Christopher J. Coughlin Insider Trading History at Centene

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
5/14/2024Sell878$76.75$67,386.5025,504View SEC Filing Icon  
See Full Table

Christopher J. Coughlin Buying and Selling Activity at Centene

This chart shows Christopher J Coughlin's buying and selling at Centene by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Centene Company Overview

Centene logo
Centene Corporation operates as a healthcare enterprise that provides programs and services to under-insured and uninsured families, commercial organizations, and military families in the United States. The company operates through Medicaid, Medicare, Commercial, and Other segments. The Medicaid segment offers health plan coverage, including medicaid expansion, aged, blind, disabled, children's health insurance program, foster care, medicare-medicaid plans, long-term services and support. This segment also provides healthcare products. The Medicare segment offers special needs and medicare supplement, and prescription drug plans. The Commercial segment provides health insurance marketplace product for individual, small, and large group commercials. It also operates clinical healthcare and pharmacies, as well as offers dental and speech therapy services. In addition, the company engages in the government contracts business under the TRICARE program and other healthcare related government contracts. It provides services through primary and specialty care physicians, hospitals, and ancillary providers. Centene Corporation was founded in 1984 and is headquartered in Saint Louis, Missouri.
Read More

Today's Range

Now: $72.08
Low: $71.68
High: $72.72

50 Day Range

MA: $75.80
Low: $70.83
High: $80.21

2 Week Range

Now: $72.08
Low: $63.45
High: $81.42

Volume

4,578,401 shs

Average Volume

3,559,960 shs

Market Capitalization

$38.47 billion

P/E Ratio

14.33

Dividend Yield

N/A

Beta

0.48